Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.648 EUR | +1.10% | -1.90% | -38.05% |
Apr. 08 | Advicenne S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 25 | Advicenne: ODD designation in cystinuria | CF |
Business Summary
At the end of 2023, the group had one product in clinical development phase: ADV7103 for the treatment of distal renal tubular acidosis and for the treatment of cystinuria.
Number of employees: 21
Sales per Business
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceuticals
100.0
%
| 3 | 100.0 % | 2 | 100.0 % | -12.32% |
Sales per region
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
European Union
95.7
%
| 3 | 97.5 % | 2 | 95.7 % | -13.91% |
Rest of the World
4.3
%
| 0 | 2.5 % | 0 | 4.3 % | +49.25% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Didier Laurens
CEO | Chief Executive Officer | 59 | 21-05-02 |
Chief Tech/Sci/R&D Officer | - | 23-03-31 | |
André Ulmann
BRD | Director/Board Member | - | 17-06-22 |
Corporate Officer/Principal | - | 21-06-30 | |
Nathalie Lemarié
LAW | General Counsel | - | 12-09-27 |
Corporate Officer/Principal | - | 07-12-31 | |
Hege Hellstrom
PRN | Corporate Officer/Principal | 59 | 20-05-25 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | - | 11-04-28 | |
Catherine Dunand
BRD | Director/Board Member | 62 | 17-03-08 |
Didier Laurens
CEO | Chief Executive Officer | 59 | 21-05-02 |
Thibaut Roulon
BRD | Director/Board Member | - | 11-04-28 |
André Ulmann
BRD | Director/Board Member | - | 17-06-22 |
Charlotte Sibley
BRD | Director/Board Member | 77 | 18-09-19 |
Hege Hellstrom
PRN | Corporate Officer/Principal | 59 | 20-05-25 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 12,446,961 | 10,980,696 ( 88.22 %) | 28,884 ( 0.2321 %) | 88.22 % |
Company contact information
Sector
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-38.05% | 21.81M | |
-3.79% | 88.14B | |
+1.45% | 40.51B | |
-15.94% | 31.67B | |
+52.66% | 24.62B | |
-14.50% | 15.65B | |
-14.38% | 12.07B | |
-9.12% | 11.97B | |
-42.56% | 11.61B | |
+4.87% | 8.81B |
- Stock Market
- Equities
- ALDVI Stock
- Company Advicenne